Condition
Acute Lymphocytic Leukemia (ALL) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Acute Lymphocytic Leukemia (ALL) clinical trials that are recruiting, in United States. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Thiotepa-based Conditioning With Reduced Post-Transplant Cyclophosphamide for Allogeneic Stem Cell Transplant in High-Risk Blood C cancers
This phase 1 trial tests a Thiotepa, Busulfan, and Fludarabine conditioning regimen with de-escalated post-transplant cyclophosphamide to see if it can improve outcomes after allogeneic stem cell transplantation for high-risk blood cancers.
-
Obecabtagene autoleucel consolidation for newly diagnosed high-risk B-cell acute lymphoblastic leukemia
This trial will test whether a single infusion of the CAR‑T therapy obecabtagene autoleucel can help keep adults with newly diagnosed high‑risk B‑cell ALL in remission when given after initial chemotherapy.
Related topics
Quick answers
How many Acute Lymphocytic Leukemia (ALL) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.